USPH Q4 2022 GAAP diluted EPS -$0.01; Adj EBITDA $17.9M; raises dividend 4.9% to $0.43

U S PHYSICAL THERAPY INC /NV

2022-FY EPS reported $2.25 revenue$553,144,000

Q4 total revenue $141.2M (+8.7% YoY); GAAP net income $2.6M vs $10.2M; diluted EPS loss $0.01 vs $0.73.
Adjusted EBITDA Q4 $17.9M, up 2.8% from $17.4M (excl. Relief Funds) in Q4 2021.
Board raises quarterly dividend 4.9% to $0.43 per share, effective immediately.
2023 guidance: Adjusted EBITDA expected $75M-$80M from existing operations.
Goodwill impairment charge of $9.1M in Q4 related to IIP Acquisition.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

U S PHYSICAL THERAPY INC /NV updated its the three months and year ended December 31, 2022 guidance (raised).

Period: the three months and year ended December 31, 2022
Guidance: raised
Result: reported results

Exact text from the filing

On February 28, 2023, U.S. Physical Therapy, Inc. ("USPH" or the “Company”) (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention (“IIP”) services, reported final results for the three months and year ended December 31, 2022 (“2022 Fourth Quarter” and “2022 Year”, respectively).

View on SEC.gov

31 earnings releases filed in the last 30 days. Browse all earnings releases →

U S PHYSICAL THERAPY INC /NV filing history →

Source: SEC EDGAR

accession 0000885978-23-000006

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.